Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan

Cutaneous malignant melanoma (MM) metastases to prostate and spleen are very rarely experienced in clinical setting. As per our knowledge, coexistence of prostate and splenic metastatic MM is not reported worldwide. We are presenting a case of 70-year-old male patients with biopsy and clinically pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Digish, Odedara, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745868/
https://www.ncbi.nlm.nih.gov/pubmed/33354185
http://dx.doi.org/10.4103/wjnm.WJNM_49_19
_version_ 1783624688314875904
author Shah, Digish
Odedara, Prakash
author_facet Shah, Digish
Odedara, Prakash
author_sort Shah, Digish
collection PubMed
description Cutaneous malignant melanoma (MM) metastases to prostate and spleen are very rarely experienced in clinical setting. As per our knowledge, coexistence of prostate and splenic metastatic MM is not reported worldwide. We are presenting a case of 70-year-old male patients with biopsy and clinically proven case of multifocal cutaneous malignant melanomatous lesions having multiple metastatic lymph nodes and systemic metastases, including prostate and spleen. This is the first case reported worldwide having a combination of prostate and splenic metastases.
format Online
Article
Text
id pubmed-7745868
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-77458682020-12-21 Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan Shah, Digish Odedara, Prakash World J Nucl Med Case Report Cutaneous malignant melanoma (MM) metastases to prostate and spleen are very rarely experienced in clinical setting. As per our knowledge, coexistence of prostate and splenic metastatic MM is not reported worldwide. We are presenting a case of 70-year-old male patients with biopsy and clinically proven case of multifocal cutaneous malignant melanomatous lesions having multiple metastatic lymph nodes and systemic metastases, including prostate and spleen. This is the first case reported worldwide having a combination of prostate and splenic metastases. Wolters Kluwer - Medknow 2020-01-17 /pmc/articles/PMC7745868/ /pubmed/33354185 http://dx.doi.org/10.4103/wjnm.WJNM_49_19 Text en Copyright: © 2020 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Shah, Digish
Odedara, Prakash
Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan
title Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan
title_full Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan
title_fullStr Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan
title_full_unstemmed Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan
title_short Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan
title_sort cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (fdg) positron emission tomography–computed tomography scan
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745868/
https://www.ncbi.nlm.nih.gov/pubmed/33354185
http://dx.doi.org/10.4103/wjnm.WJNM_49_19
work_keys_str_mv AT shahdigish cutaneousmalignantmelanomawithrarestcombinationofprostaticandsplenicmetastasesonfluorodeoxyglucosefdgpositronemissiontomographycomputedtomographyscan
AT odedaraprakash cutaneousmalignantmelanomawithrarestcombinationofprostaticandsplenicmetastasesonfluorodeoxyglucosefdgpositronemissiontomographycomputedtomographyscan

Ejemplares similares